APOE and cancer: For example, Tavazoie et al.29 showed that apolipoprotein E (ApoE), which is transcriptionally activated by liver X nuclear receptor (LXR), reduces the survival levels of both tumoral and circulating granulocytic and monocytic MDSCs by triggering apoptosis in mouse and human cancer models [Figure 1A(3)].